Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke

Brain Research Bulletin

Volumn 48, Issue 3, 1999, Pages 325-331

  Lew, Sean M ^a   Gross, Cordell E ^a   Bednar, Martin M ^a   Russell, Sheila J ^a   Fuller, Susan P ^a   Ellenberger, Carolyn L ^a   Howard, Diantha ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Cerebral ischemia; Cobra venom factor; Complement system; Ischemia reperfusion injury; Neutrophils; Tissue plasminogen activator

Indexed keywords

COMPLEMENT; SNAKE VENOM; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG EFFECT; INTERNAL CAROTID ARTERY; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; STROKE; THROMBOEMBOLISM;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COBRA VENOMS; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; FIBRINOLYTIC AGENTS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; NEUTROPHILS; RABBITS; REPERFUSION INJURY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032948941     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00004-0     Document Type: Article

References (57)

1. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular immunology. 1991;W. B. Saunders, Philadelphia.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Eng. J. Med. 333:1995;1581-1587.
3. Aukland K., Bower B.F., Berliner R.W. Measurement of local blood flow with hydrogen gas. Circ. Res. 14:1964;164-187.
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 6:1986;1304-1308.
5. Bednar M.M., Dooley R.H., Zamani M., Howard D.B., Gross C.E. Neutrophil and platelet activity and quantification following delayed tPA therapy in a rabbit model of thromboembolic stroke. J. Thrombosis Thrombolysis. 1:1995;179-185.
6. Bednar M.M., Fanburg J.C., Anderson M.L., Raymond S.J., Dooley R.H., Gross C.E. Comparison of triphenyltetrazolium dye with light microscopic evaluation in a rabbit model of acute cerebral ischaemia. Neurol. Res. 16:1994;129-132.
7. Bednar M.M., Gross C.E., Balazy M., Falck J.R. Antineutrophil strategies. Neurology. 49:(5 Suppl. 4):1997;S20-S22.
8. Bednar M.M., Gross C.E., Howard D.B., Lynn M. Neutrophil activation in acute human central nervous system injury. Neurol. Res. 19:1997;588-592.
9. Bednar M.M., Gross C.E., Russell S.R., Fuller S.P., Ellenberger C.L., Schindler E., Klingbeil C., Vexler V. Humanized anti-L-selectin monoclonal antibody DREG200 therapy in acute thromboembolic stroke. Neurol. Res. 20:1998;405-408.
10. Bednar M.M., Gross C.E., Russell S.R., Short D., Giclas P.C. Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke. J. Neurosurg. 86:1997;139-142.
11. Bednar M.M., McAuliffe T., Raymond S., Gross C.E. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke. Stroke. 21:1990;1705-1709.
12. Bednar M.M., Raymond S.J., Gross C.E. Tissue plasminogen activator Comparison of dose and route of administration in a rabbit model of thromboembolic stroke . Neurol. Res. 15:1993;405-408.
13. Bednar M.M., Raymond S., McAuliffe T., Lodge P.A., Gross C.E. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke. 22:1991;44-50.
14. Bednar M.M., Wright S.D., Raymond-Russell S.J., Kohut J.J., Gross C.E. IB4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rabbit. Neurol. Res. 18:1996;171-175.
15. Bennett W.R., Yawn D.H., Migliore P.J., Young J.B., Pratt C.M., Raizner A.E., Roberts R., Bolli R. Activation of the complement system by a recombinant tissue plasminogen activator. J. Am. Coll. Cardiol. 10:1987;627-632.
16. Braquet P., Paubert-Braquet M., Koltai M., Bourgain R., Bussolino F., Hosford D. Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol. Sci. 10:1989;23-30.
17. Chen H., Chopp M., Zhang R.L., Bodzin G., Chen Q., Rusche J.R., Todd R.F. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35:1994;458-463.
18. Chen J., Weinstein P.R., Graham S.H. Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C. J. Neurosurg. 83:1995;99-104.
19. Chopp M., Zhang R.L., Chen H., Li Y., Jiang N., Rusche J.R. Postischemic administration of an anti-Maci-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 25:1994;869-875.
20. Craddock P.R., Hammerschmidt D.E., Moldow C.F., Yamada O., Jacob H.S. Granulocyte aggregation as a manifestation of membrane interactions with complement; possible role in leukocyte margination, microvascular occlusion, and endothelial damage. Semin. Hematol. 16:1979;140-147.
21. Craddock P.R., Hammerschmidt D., White J.G., Dalmasso A.P., Jacob H.S. Complement (C5a)-induced granulocyte aggregation in vitro a possible mechanism of complement-mediated leukostasis and leukopenia . J. Clin. Invest. 60:1977;260-264.
22. Davis W.D., Brey R.L. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin. Exp. Rheumatol. 10:1992;455-460.
23. del Zoppo G.J., Schmid-Schonbein G.W., Mori E., Copeland B.R., Chang C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 22:1991;1276-1283.
24. Dutka A.J., Kochanek P.M., Hallenbeck J.M. Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. Stroke. 20:1989;390-395.
25. Fernandez H.N., Henson P.M., Otani A., Hugli T.E. Chemotactic response to human C3a and C5a anaphylotoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol. 120:1978;109-115.
26. Fishbein M.C., Meervaum S., Rit J., Lando U., Kanmatsuse K., Mercier J.C., Corday E., Ganz W. Early phase acute myocardial infarct size quantification. Validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am. Heart J. 101:1981;593-599.
27. Galli C., Petroni A., Bertazzo A., Sarti S. Arachidonic acid and its metabolites during cerebral ischemia and recirculation. Pharmaclogical interventions. Ann. N. Y. Acad. Sci. 559:1989;352-364.
28. German J.W., Gross C.E., Giclas P., Watral W., Bednar M.M. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery. 39:1996;141-146.
29. Grogaard B., Schurer L., Gerdin B., Arfors K.E. Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes. J. Cereb. Blood Flow Metab. 9:1989;500-505.
30. Gross C.E., Raymond S.J., Howard D.B., Bednar M.M. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke. Neurosurgery. 36:1995;1172-1177.
31. Hart R., Schurer L., Schmid-Schonbein G.W., del Zoppo G.J. Experimental antileukocyte interventions in cerebral ischemia. J. Cereb. Blood Flow Metab. 16:(6):1996;1108-1119.
32. Heideman M., Norder-Hansson B., Bengston A., Mollnes T.E. Terminal complement complexes and anaphylotoxins in septic and ischemic patients. Arch. Surg. 123:1988;188-192.
33. Hill J.H., Ward P.A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133:1971;885-900.
34. Hoffman S.A., Arbogast D.N., Day T.T., Shucard D.W., Harbeck R.J. Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease. J. Immunol. 130:1983;1695-1698.
35. Homeister J.W., Satoh P., Lucchesi B.R. Effects of complement activation in the isolated heart Role of the terminal complement components . Circ. Res. 71:1992;303-319.
36. Ikeda Y., Long D.M. The molecular basis of brain injury and brain edema The role of oxygen free radicals . Neurosurgery. 27:1990;1-11.
37. Kabat, E. A., Mayer, M. M. Experimental immunochemistry, 2nd ed. Springfield, IL: Charles C Thomas; 1961.
38. Leventhal J.R., Dalmasso A.P., Cromwell J.W., Platt J.L., Manivel C.J., Bolman R.M. III, Matas A.J. Prolongation of cardiac xenograft survival by depletion of complement. Transplant. 55:1993;847-865.
39. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
40. Marie C., Bralet J. Blood glucose level and morphological brain damage following cerebral ischemia. Cerebrovasc Brain Metab Rev. 3:(1):1991;29-38.
41. Maroko P., Carpenter C., Chiariello M., Fishbein M.C., Radvany P., Knostman J.D., Hale S.L. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest. 61:1978;661-670.
42. Mathieson P.W., Qasim F.J., Thiru S., Oldroyd R.G., Oliveira D.B. Effects of decomplementation with cobra venom factor on experimental vasculitis. Clin. Exp. Immunol. 97:1994;474-477.
43. Matsuo Y., Kihara T., Ikeda M., Ninomiya M., Onodera H., Kogure K. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain Effect of neutrophil depletion on extracellular ascorbyl radical formation . J. Cereb. Blood Flow Metab. 15:1995;941-947.
44. Matsuo Y., Kihara T., Ikeda M., Ninomiya M., Onodera H., Kogure K. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. Brain. Res. 709:(2):1996;296-302.
45. Matsuo Y., Onodera H., Shiga Y., Shozuhara H., Ninomiya M., Kihara T., Tamatani T., Miyasaka M., Kogure K. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656:1994;344-352.
46. McGrath J.C., MacKenzie J.E., Millar R.A. Circulatory responses to ketamine Dependence on respiratory pattern and background anaesthesia in the rabbit . Br. J. Anaesth. 47:1975;1149-1156.
47. Mori E., del Zoppo G.J., Chambers J.D., Copeland B.R., Arfors K.E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke. 23:1992;712-718.
48. Overgaard K., Sereghy T., Pedersen H., Boysen G. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J. Cereb. Blood Flow Metab. 14:1994;472-477.
49. Pinckard R., O'Rourke R., Crawford M., Grover F.S., McManus L.M., Ghidoni J.J., Storrs S.B., Olson M.S. Complement localization and mediation of ischemic injury in baboon myocardium. J. Clin. Invest. 66:1980;1050-1056.
50. Thomas G.R., Thibodeaux H., Bennett W.F., Refino C.J., Badillo J.M., Errett C.J., Zivin J.A. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. J. Pharmacol. Exp. Ther. 264:1993;67-73.
51. Umemura K., Wada K., Uematsu T., Nakashimi M. Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery. Stroke. 24:1993;1077-1081.
52. Van den Berg C.W., Aerts P.C., Van Dijk H. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J. Immunol. Methods. 136:1991;287-294.
53. Vasthare U.S., Barone F.C., Sarau H.M., Rosenwasser R.H., DiMartino M., Young W.F., Tuma R.F. Complement depletion improves neurological function in cerebral ischemia. Brain Res. Bull. 45:1998;413-419.
54. Voll C.L., Auer R.N. The effect of postischemic blood glucose levels on ischemic brain damage in the rat. Ann. Neurol. 24:(5):1988;638-646.
55. Wang Y.F., Tsirka S.E., Stickland S., Soriano S.G., Lipton S.A. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and TPA-deficient mice. Nat Med. 4:1998;228-231.
56. Yanomoto H., Kikuchi H., Okamoto S., Nozaki K. Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits. Neurosurgery. 30:1992;351-357.
57. 2 clearance measurement of blood flow A review of technique and polarographic principles . Stroke. 11:1980;552-564.